The serum level of IL-17 was significantly increased in both the NASH patients and the NASH patients with fibrosis with P = 0.0332 and P = 0.0001, respectively (Figure 3(a)). The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.